A Cellular Defect in Hereditary Vitamin-D-Dependent Rickets Type II: Defective Nuclear Uptake of 1,25-Dihydroxyvitamin D in Cultured Skin Fibroblasts

Charles Eil, Uri A. Liberman, John F. Rosen, Stephen J. Marx*, Stephen J. Marx*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

99 Scopus citations

Abstract

VITAMIN-D-dependent (or pseudo-vitamin-D-deficient) rickets is characterized by clinical and biochemical features of vitamin-D-deficient rickets and by remission of these features during treatment with supraphysiologic doses of vitamin D or of 25-hydroxyvitamin D (25-(OH)D).1,2 It is often hereditary, with patterns suggestive of autosomal-recessive transmission. In members of several kindreds who are classified as having vitamin-D-dependent rickets Type I, concentrations of 1,25-dihydroxyvitamin D (1,25(OH)2D) in serum have been low3,4; these patients can be treated with doses of 1,25-dihydroxycholecalciferol (1,25-(OH)2D3) that are estimated to maintain a normal average serum concentration and turnover of this metabolite.3 Presumably,. . .

Original languageEnglish
Pages (from-to)1588-1591
Number of pages4
JournalNew England Journal of Medicine
Volume304
Issue number26
DOIs
StatePublished - 25 Jun 1981
Externally publishedYes

Fingerprint

Dive into the research topics of 'A Cellular Defect in Hereditary Vitamin-D-Dependent Rickets Type II: Defective Nuclear Uptake of 1,25-Dihydroxyvitamin D in Cultured Skin Fibroblasts'. Together they form a unique fingerprint.

Cite this